文献速递免疫规划妇幼与学校卫生

孕期流感疫苗接种与胎儿丢失相关风险:基于理赔数据的前瞻性队列研究

Maternal influenza vaccination and associated risk of fetal loss: A claims-based prospective cohort study.
PubMed 文献 · Vaccine · 2024-09-10

该研究利用美国Optum Labs数据仓库2009年1月至2018年12月间117,626例妊娠的理赔数据,采用时变暴露Cox模型分析孕期流感疫苗接种与胎儿丢失风险。结果显示,孕期接种者流产风险较未接种者低39%(aHR 0.61;95%CI 0.50, 0.74),医疗终止妊娠和死产风险相似;孕前接种与胎儿丢失风险关联很小或无关联。结论支持流感疫苗在孕前或孕早期接种的安全性。

要点

  • 孕期接种流感疫苗与流产风险降低相关(aHR 0.61;95%CI 0.50, 0.74)。
  • 孕前接种与流产、医疗终止或死产风险无显著关联。
  • 孕期接种未增加医疗终止或死产风险(aHR 0.69 和 0.99)。

核心结论

  • 流感疫苗接种与胎儿丢失风险增加无关。
  • 结果支持流感疫苗在孕前或孕早期接种的安全性。

研究设计与样本

  • 基于Optum Labs数据仓库全国去标识理赔数据的前瞻性队列研究。
  • 纳入2009年1月至2018年12月间117,626例妊娠。
  • 使用Cox比例风险模型,将流感疫苗接种作为时变暴露,对失访加权并按基线接种概率分层。

主要发现

  • 31.4%的队列有流感疫苗接种记录;10.0%仅孕前接种,17.8%仅孕期接种,3.6%孕前和孕期均接种。
  • 孕期接种者流产风险较未接种者低39%(aHR 0.61;95%CI 0.50, 0.74)。
  • 孕期接种者医疗终止风险(HR 0.69;95%CI 0.45, 1.03)和死产风险(aHR 0.99;95%CI 0.76, 1.30)与未接种者相似。
  • 孕前接种与流产(HR 0.98;95%CI 0.76, 1.26)、医疗终止(HR 1.02;95%CI 0.46, 2.24)或死产(HR 1.14;95%CI 0.77, 1.69)风险关联很小或无关联。
  • 孕前和孕期均接种的女性观察到相似结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although numerous studies support the safety of influenza vaccination during pregnancy, fewer studies have evaluated the risk of miscarriage or considered the effect of prior immunization. METHODS: Using national de-identified administrative claims data from the Optum Labs Data Warehouse, we conducted a claims-based cohort study of 117,626 pregnancies between January 2009 and December 2018. We identified pandemic A(H1N1)pdm09 and seasonal influenza vaccinations using CPT codes. Fetal loss was defined as miscarriage, medical termination, or stillbirth as identified by ICD-10-CM diagnostic codes. Cox proportional hazard models treating influenza vaccination as a time-varying exposure, weighted for loss-to-follow-up and stratified by baseline probability of vaccination, were used to model the risk of fetal loss by exposure to influenza vaccine. RESULTS: About 31.4 % of the cohort had a record of influenza vaccination; 10.0 % were vaccinated before pregnancy only, 17.8 % during pregnancy only, and 3.6 % before and during pregnancy. The risk of miscarriage was 39 % lower among those vaccinated during pregnancy compared to unvaccinated (adjusted hazard ratio, aHR 0.61; 95 % CI 0.50, 0.74) and was similar for medical termination or stillbirth (HR 0.69; 95 % CI 0.45, 1.03 and aHR 0.99; 95 % CI 0.76, 1.30, respectively). Similar results were observed for women who received the vaccine before and during pregnancy. We observed little to no association between vaccination before pregnancy and risk of miscarriage (HR 0.98; 95 % CI 0.76, 1.26), medical termination (HR 1.02; 95 % CI 0.46, 2.24), or stillbirth (HR 1.14, 95 % CI 0.77, 1.69). DISCUSSION: Influenza vaccination was not associated with an increased risk of fetal loss. These results support the safety of influenza vaccine administration even when administered before or early during pregnancy.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Regan AK, Sullivan SG, Arah OA, et al. Maternal influenza vaccination and associated risk of fetal loss: A claims-based prospective cohort study. Vaccine. 2024. PMID: 39260053. doi:10.1016/j.vaccine.2024.126256

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。